Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for long-term outcomes in elderly post-noncardiac surgery patients
NCT02809937Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- May 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in postoperative delirium (POD), sponsored by Peking University First Hospital. Primary endpoint: Duration of survival after surgery at 3 years. Started May 2011; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT02809937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809937.